Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach

Autor: Davide Arillotta, Giuseppe Floresta, G. Duccio Papanti Pelletier, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano

Publikováno v: Brain Sciences, Vol 14, Iss 6, p 617 (2024)

Glucagon-like peptide-1 (GLP-1) is involved in a range of central and peripheral pathways related to appetitive behavior. Hence, this study explored the effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) on substance and behavioral addi

Externí odkaz: https://doaj.org/article/aa7c9e3fb79a4428b229d3fc4c021e21

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset

Autor: Stefania Chiappini, Rachel Vickers-Smith, Daniel Harris, G. Duccio Papanti Pelletier, John Martin Corkery, Amira Guirguis, Giovanni Martinotti, Stefano L. Sensi, Fabrizio Schifano

Publikováno v: Pharmaceuticals, Vol 16, Iss 7, p 994 (2023)

Recent media reports commented about a possible issue of the misuse of antidiabetics related to molecules promoted as a weight-loss treatment in non-obese people. We evaluated here available pharmacovigilance misuse/abuse signals related to semagluti

Externí odkaz: https://doaj.org/article/6e0e9a23396b445b9671d99a2a4181da

Novel psychoactive substances: the pharmacology of stimulants and hallucinogens

Autor: Laura Orsolini, John Corkery, G Duccio Papanti, Fabrizio Schifano

Publikováno v: Expert Review of Clinical Pharmacology. 9:943-954

There are increasing levels of concern relating to the rapidly evolving novel psychoactive substances/NPS and web markets' scenarios. The paper aims at providing an overview of the clinical pharmacological issues related to some of the most popular N

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f535cf826ede71937a44d00053287b3
https://doi.org/10.1586/17512433.2016.1167597

Novel psychoactive substances of interest for psychiatry

Autor: John Corkery, G Duccio Papanti, Laura Orsolini, Fabrizio Schifano

Publikováno v: World Psychiatry. 14:15-26

Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine-like dissociatives, piperazines, GABA-A/B receptor agonists,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea33ea239ff23711f0eec949090aa27d
https://doi.org/10.1002/wps.20174

Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective.

Autor: Chiappini S; UniCamillus University of Medical Sciences, Via di S. Alessandro 8, Rome, Italy., Guirguis A; Pharmacy, Swansea University Medical School, The Grove, Swansea University, SA2 8PP, Swansea, Wales, UK. Electronic address: amira.guirguis@swansea.ac.uk., Schifano N; Department of Urology, ASST Sette Laghi, Varese, Italy; Circolo & Fondazione Macchi Hospital; University of Insubria, Varese, Italy., Corkery JM; Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, AL10 9AB Hertfordshire, UK. Electronic address: j.corkery@herts.ac.uk., Semeraro F; Department of Neuroscience, Imaging and Clinical Sciences, 'G. D'Annunzio' University, 66100 Chieti, Italy., Mosca A; Department of Neuroscience, Imaging and Clinical Sciences, 'G. D'Annunzio' University, 66100 Chieti, Italy., D'Andrea G; Department of Neuroscience, Imaging and Clinical Sciences, 'G. D'Annunzio' University, 66100 Chieti, Italy., Duccio Papanti G; Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, AL10 9AB Hertfordshire, UK; Tolmezzo Community Mental Health Centre, ASUFC Mental Health and Addiction Department, via Bonanni 2, 33028 Tolmezzo, UD, Italy., Arillotta D; Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, AL10 9AB Hertfordshire, UK; Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Viale G. Pieraccini, 6, 50139 Florence, Italy., Floresta G; Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, AL10 9AB Hertfordshire, UK; Department of Drug and Health Sciences, University of Catania, Catania, Italy. Electronic address: giuseppe.floresta@unict.it., Martinotti G; Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, AL10 9AB Hertfordshire, UK; Department of Neuroscience, Imaging and Clinical Sciences, 'G. D'Annunzio' University, 66100 Chieti, Italy., Schifano F; Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, AL10 9AB Hertfordshire, UK. Electronic address: f.schifano@herts.ac.uk.

Publikováno v: Progress in neuro-psychopharmacology & biological psychiatry [Prog Neuropsychopharmacol Biol Psychiatry] 2024 Dec 06; Vol. 136, pp. 111213. Date of Electronic Publication: 2024 Dec 06.